FDA
-
-
-
-
-
-
-
Advicenne Reaches a Significant Milestone With the US FDA in the Development of ADV7103 in Cystinuria
-
-
-
-
-
-
-
Advicenne Reports its First Half Financial Results as of June 30, 2023 and Updates on Its Activities
-
-
-
-
-
328,148 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

